ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1256

Self-esteem and Body Image of Young People with Rheumatic Diseases: A Systematic Review

Leticia Leon1, Daniel clemente Garulo2, Carmen Heredia3 and lydia Abasolo4, 1Fundación Investigación Biomédica Hospital Clínico San Carlos, Madrid, Spain, 2Pediatric Rheumatology Unit, Hospital Niño Jesús, Madrid, Spain, 3Universidad Camilo Jose Cela, Madrid, Spain, 4Hospital Clínico San Carlos, Madrid, Spain

Meeting: ACR Convergence 2023

Keywords: Pediatric rheumatology, psychosocial factors

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 13, 2023

Title: (1256–1263) Psychology/Social Science – Interprofessional Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Little is known about the self-esteem and body image impact in young people with rheumatic and musculoskeletal diseases (RMD). Studies in chronic illness suggest that chronic health conditions can develop changes in appearance, or social activities disruption, consequentially body image and self-esteem can be altered mainly in young people. The purpose of this study was to synthesize existing research related to self-esteem and body image in young people with RMD.

Methods: Databases (MEDLINE, Embase, PsycINFO, and CINAHL) were searched until April 2023. Results were limited to English-language studies. Studies were screened and evaluated for inclusion by two investigators. The systematic review included: a) All original articles reporting self-esteem or body image of young people with RMDs ; b) Qualitative studies (data obtained through individual interview and/or focus groups), quantitative studies (information obtained through questionnaires) or c) mixed designs (articles including qualitative and quantitative methods) Case studies, letters to the editor and commentaries were excluded. Additionally, a manual search was undertaken wherein reference lists of selected articles were screened for inclusion.

Results: Twelve articles were eligible for inclusion in the present review. Eligible studies were identified for juvenile idiopathic arthritis (6), lupus (3), scleroderma (2), and vasculitis (1). As main results we highlight the following: Glucocorticoids use was found to consistently associate with poor body image, in all conditions (due to visible side-effects of medication). Greater body image concerns were associated with facial lesions, and the resulting perceived stigma (this appearance concern was also related to depression). Females showed lower self-esteem than males. Anxiety and apprehension about their physical and sexual attractiveness was associated with lower self-esteem. Feeling of restrictions in their experimentation with drinking and sexual relations also impacted their self-esteem. A lower self-esteem was associated with poor QoL, and regarding DMARDs treatments, use of IL-6 treatment improved self-esteem.

Conclusion: The use of disease-specific measures and the heterogeneous group of studies complicated the synthesis of the findings. However, some factors appeared most associated with poorer self-esteem and body image across disease groups. Young people with RMD, who already face additional medical and psychosocial burden, might benefit from monitoring tools and interventions designed to improve their body image and bolster self-esteem in the ongoing context of self-care and adherence. Moreover, understanding these issues can help in treatment planning, and clinical decision-making for this population.


Disclosures: L. Leon: Pfizer, 6; D. clemente Garulo: Eli Lilly, 5, GlaxoSmithKlein(GSK), 6, Pfizer, 6, Sanofi, 5; C. Heredia: None; l. Abasolo: None.

To cite this abstract in AMA style:

Leon L, clemente Garulo D, Heredia C, Abasolo l. Self-esteem and Body Image of Young People with Rheumatic Diseases: A Systematic Review [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/self-esteem-and-body-image-of-young-people-with-rheumatic-diseases-a-systematic-review/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/self-esteem-and-body-image-of-young-people-with-rheumatic-diseases-a-systematic-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology